Pharmaceutical Business review

GeneGo Licenses MetaCore To University of Maryland School of Nursing

GeneGo claims that the latest version, MetaCore 6.0, includes a new easy to use interface with interactome analysis tools, simple searching of GeneGo’s manually curated content, and direct links from the drug detail pages to Sigma Aldrich for purchasing compounds.

Susan Dorsey, director of pain studies at UMB Center, said: We prefer the coverage and quality of disease annotation, as well as the rodent specific pathway analysis, which is critical to seeing species differences. I am not aware of another platform that has this capability.”

Julie Bryant, VP of business development at GeneGo, said: We are always told that we have the broadest and deepest coverage of content in the systems biology pathway area with the highest quality manual curation, As we focus on building our disease platforms our depth of coverage will continue to grow and provide more levels of granularity for our users on diseases, processes and toxicology.